Welcome to The Ammon-Pinizzotto Center for Women’s Mental Health at MGH. Our Center, established in 1989, has been renamed following the generous gift from Carol Ammon and Dr. Marie Pinizzotto. These resources will be used to realize the overarching mission of the Center.
This website provides a range of current information including discussion of new research findings in women’s mental health and how such investigations inform day-to-day clinical practice. Despite the growing number of studies being conducted in women’s health, the clinical implications of such work are frequently controversial, leaving patients with questions regarding the most appropriate path to follow. Providing these resources to patients and their doctors so that individual clinical decisions can be made in a thoughtful and collaborative fashion dovetails with the mission of our Center.
All pregnant women ages 18-45 are eligible to enroll in the registry. We are currently seeking both controls and those being treated with atypical antipsychotics and/ or antidepressants.
This study will involve 3 brief phone interviews over an 8-month period. The National Pregnancy Registry for Psychiatric Medications is dedicated to evaluating the safety of psychiatric medications that may be taken by women during pregnancy to treat a wide range of mood, anxiety, or psychiatric disorders. The primary goal of this Registry is to determine the frequency of major malformations, such as heart defects, cleft lip, or neural tube defects, in infants exposed to atypical antipsychotics and antidepressants during pregnancy. For more information, please call 1-866-961-2388 or e-mail email@example.com.
Help make the future better for many other women like you.
The MGH Center for Women’s Mental Health
Perinatal and Reproductive Psychiatry Program
Simches Research Building
185 Cambridge St Suite 2200
Boston, MA 02114
To make an appointment:
Massachusetts General Hospital Clinical Program: (617) 724-7792
Location of appointments:
Wang Ambulatory Care Center, Massachusetts General Hospital
15 Parkman St., Floor 8
Boston, MA 02114-3117
September 28, 2016
Women with bipolar disorder are at a higher risk for relapse during pregnancy and that the risk is even higher during the postpartum period. In addition, women with bipolar disorder are more vulnerable to postpartum psychosis. It is for these reasons that we typically recommend that women with bipolar disorder maintenance treatment with a mood ...Read more
Depression Trajectories Across the Peripartum Period: Many Women Depressed During the First Postpartum Year
September 26, 2016
In the earliest studies, postpartum depression was described an episode of depression associated with childbirth, typically emerging within the first three months after delivery. As more research has been carried out, we have learned that a sizeable number of women with PPD actually begin to experience symptoms during pregnancy. The bottom line is that women ...Read more
September 23, 2016
This week’s roundup includes a series of articles on depression in menopausal women. Reducing depression during the menopausal transition with health coaching: Results from the healthy menopausal transition randomised controlled trial. Almeida OP, Marsh K, Murray K, Hickey M, Sim M, Ford A, Flicker L. Maturitas. 2016 Oct;92:41-8. doi: 10.1016/j.maturitas.2016.07.012. Epub 2016 Jul 19. Depressive symptoms across the menopause ...Read more
September 20, 2016
Multiple studies have demonstrated the effectiveness of antidepressant medications for the treatment of postpartum depression (PPD). Most of the these studies focused on the impact of these medications on depressive symptoms; however, it is clear that many, or maybe most, women with PPD also have significant anxiety symptoms. Thus, we can hypothesize that medications which ...Read more
September 17, 2016
Heading the list are two important reviews: one on postpartum psychosis from the American Journal of Psychiatry and another on the topic of perinatal suicide. On the list, you will also find several interesting articles on the association between infertility treatment and postpartum depression (Tendais andFigueiredo, Gressier et al). Postpartum Psychosis: Madness, Mania, and Melancholia in ...Read more
September 13, 2016
The Edinburgh Postnatal Depression Scale (EPDS) is the screening instrument most commonly used to identify women with postpartum mood disorders. This is a 10-item questionnaire which has been validated in many different populations and is available in almost every language. On this scale, a score of 10 or greater or an affirmative answer on question ...Read more